ABS

Bank underwriters across the U.S. and Europe are pulling sales and pausing future ones amid tepid demand. Barclays Plc recently shelved a pair of loans for Ineos Enterprises and Russell Investments, while JPMorgan Chase & Co. yanked a deal for Agiliti Health.

The deal's total leverage is 11.25%, subordination is 13.14%, it has a WA cost of debt of 2.35%, and a WA spread of 3.49%, excluding floors.

SVB, First Republic and PacWest play a variety of roles in several RMBS, but structural protections are walling off the deals from current tremors in the banking sector.

As it turns out, the plan was designed to buy time for the financial regulator Finma and the Swiss National Bank to secure a sale — not for Credit Suisse to rescue itself.

The volatile securitization market fueled the structured-loan provider's record business last year.

Unlike many non-prime RMBS transactions, BSI Financial Services, the servicer, is not required to make any principal and interest (P&I) payments on any mortgage loans that it services.

Market pricing for the Fed's March 21-22 meeting has lurched between another quarter-point hike, and the first rate pause in more than a year.

Regulators saved lenders from a proliferation of banking issues in response to Silicon Valley Bank's collapse—and cemented the virtues of the borrow-lend strategy of CLOs.

Initially, charges start at 4% of a customer's total bill. Yet a 10% is also tacked on from similar 2014 bonds.

Santander Consumer USA on Wednesday delayed the sale of $942 million of bonds backed by subprime auto loans as the deepening Credit Suisse Group AG crisis added to turmoil in debt markets.